Correction: Molecular insights into prognostic model for meningiomas treated with stereotactic radiosurgery: negative impacts of 1q gain on tumor control and survival Authors: Motoyuki Umekawa, Yuki Shinya, Yudai Hirano, Satoru Miyawaki, Hirotaka Hasegawa, Yu Sakai, Yu Teranishi, Shotaro Ogawa, Atsuto Katano, Daisuke Komura, Hiroto Katoh, Masako Ikemura, Hideaki Ono, Tetsuo Ushiku, Shumpei Ishikawa, Nobuhito Saito Published: 2025 Correction to: Acta Neuropathologica Communications (2025) 13:232 10.1186/s40478-025-02153-2 In this article [1], Fig. 2 appeared incorrectly and have now been corrected in the original publication. For completeness and transparency, the old incorrect versions are displayed below. Incorrect Fig. 2. A Kaplan–Meier curves for the cumulative progression-free survival (PFS) rates of patients with meningiomas after stereotactic radiosurgery in the entire cohort; B PFS rates comparing molecular groups. C Kaplan–Meier curves for the cumulative and disease-specific survival (DSS) rates of patients with meningiomas after stereotactic radiosurgery in the entire cohort; D DSS rates comparing molecular groups Corrected Fig. 2. A Kaplan–Meier curves for the cumulative progression-free survival (PFS) rates of patients with meningiomas after stereotactic radiosurgery in the entire cohort; B PFS rates comparing molecular groups. C Kaplan–Meier curves for the cumulative and disease-specific survival (DSS) rates of patients with meningiomas after stereotactic radiosurgery in the entire cohort; D DSS rates comparing molecular groups Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References